| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Pharmaceuticals & Drugs
|
Compare with Industry peers |
| Website | http://www.decipherlabs.in | |
| Market Cap | 18.18 Cr. | |
| Enterprise Value(EV) | 18.18 Cr. | 2023-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | -14.77 | Trailing Twelve Months Ending 2023-09 |
| Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2023-09 |
| Industry PE | 38.37 | Trailing Twelve Months Ending 2023-09 |
| Book Value / Share | 20.40 | Trailing Twelve Months Ending 2023-09 |
| Price to Book Value | 0.88 | Calculated using Price: 18.00 |
| Dividend Yield | 0.00 | Period Ending 2023-03 |
| No. of Shares Subscribed | 1.01 Cr. | 10,100,000 Shares |
| FaceValue | 10 | |
| About Decipher Labs Ltd. | ||
| Combat is a professionally managed, well established public limited company, engaged in the manufacture & marketing of Pharmaceutical Formulations since its incorporation in 1986. The company has been marketing its branded formulations and entering into agreements with various companies for custom manufacturing and has grown to be known as a quality provider. | ||
| 1 Day |
|
+0.39% |
| 1 Week |
|
+7.04% |
| 1 Month |
|
-2.95% |
| 3 Month |
|
+12.43% |
| 6 Month |
|
+0.89% |
| 1 Year |
|
-43.38% |
| 2 Year |
|
-72.36% |
| 5 Year |
|
-19.78% |
| 10 Year |
|
-26.16% |
| 6 years | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
| Return on Equity (%) | 8.60 | 17.45 | 14.59 | 10.69 | 60.15 | -11.32 | |
| Return on Capital Employed (%) | 8.10 | 17.95 | 18.11 | 13.09 | 40.71 | -12.54 | |
| Return on Assets (%) | 6.16 | 8.71 | 5.28 | 3.79 | 28.24 | -7.76 |
| Particulars | 7 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
| Shh. Funds | 2 | 3 | 13 | 14 | 24 | 23 | 21 | |
| Non Curr. Liab. | 1 | 8 | 7 | -1 | -1 | |||
| Curr. Liab. | 1 | 4 | 21 | 17 | 11 | 5 | 3 | |
| Minority Int. | ||||||||
| Equity & Liab. | 3 | 6 | 35 | 39 | 42 | 27 | 23 | |
| Non Curr. Assets | 0 | 13 | 16 | 4 | 7 | 7 | ||
| Curr. Assets | 3 | 6 | 23 | 23 | 38 | 20 | 17 | |
| Misc. Exp. not W/O | ||||||||
| Total Assets | 3 | 6 | 35 | 39 | 42 | 27 | 23 |
| Particulars | 7 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09 Rs. Cr. TTM |
| Net Sales | 1 | 8 | 24 | 56 | 65 | 46 | 38 | |
| Other Income | 0 | 0 | 1 | 8 | 7 | -2 | ||
| Total Income | 1 | 8 | 24 | 56 | 73 | 53 | 36 | |
| Total Expenditure | -1 | -8 | -21 | -52 | -59 | -54 | -47 | |
| PBIDT | 0 | 0 | 3 | 4 | 14 | -1 | -11 | |
| Interest | 0 | -1 | -1 | 0 | 0 | 0 | ||
| Depreciation | -1 | -1 | -1 | 0 | 0 | |||
| Taxation | 0 | 0 | -1 | -1 | 1 | -1 | ||
| Exceptional Items | -2 | -2 | ||||||
| PAT | 0 | 0 | 1 | 1 | 11 | -3 | -15 | |
| Minority Interest | ||||||||
| Share Associate | ||||||||
| Other Related Items | ||||||||
| Consolidated Net Profit | 0 | 0 | 1 | 1 | 11 | -3 | -15 | |
| Adjusted EPS | 0 | 1 | 1 | 1 | 11 | -3 | -15 |
| Particulars | 6 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
| Cash Fr. Operatn. | 0 | 0 | -15 | 2 | 8 | -2 | |
| Cash Fr. Inv. | 0 | 0 | 0 | 0 | -4 | ||
| Cash Fr. Finan. | 0 | 0 | 16 | 4 | 1 | -2 | |
| Net Change | 0 | 0 | 1 | 6 | 9 | -8 | |
| Cash & Cash Eqvt | 0 | 0 | 1 | 7 | 15 | 7 |
|
Tue, 14 Nov 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication Publication of un audited financial results ( Standalone and Consolidated) for the quarter ended 30.09.2023 |
|
Fri, 10 Nov 2023
Board Meeting Outcome for Outcome Of Board Meeting For The Quarter 30.09.2023 Under Regulation 30 And 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. Outcome of Board Meeting for the quarter 30.09.2023 under regulation 30 and 33 of SEBI (Listing Obligations and Disclosure requirements) Regulations 2015. |
|
Fri, 10 Nov 2023
Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended 30.09.2029 Outcome of the Board Meeting for the quarter ended 30.09.2023 |
| Mon, 11 Dec 2023 |
High Decrease in 1 Year
|
High Decrease in 2 Years
|
5 SMA Crossing 20 SMA From Below
|
CCI Bearish
|
| Fri, 08 Dec 2023 |
Close Above Last Week High
|
Equities
M.F.
Sectors
StockEdge Social